Results 21 to 30 of about 768,553 (208)

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

New England Journal of Medicine, 2015
BACKGROUND The investigational 9-valent viruslike particle vaccine against human papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6, 11, 16, and 18) and five additional oncogenic types (31, 33, 45, 52, and 58).
E. Joura, A. Giuliano, O. Iversen, C. Bouchard, C. Mao, J. Mehlsen, E. Moreira, Y. Ngan, L. K. Petersen, E. Lazcano-Ponce, P. Pitisuttithum, J. Restrepo, G. Stuart, L. Woelber, Yuh Cheng Yang, J. Cuzick, S. Garland, W. Huh, S. Kjaer, Oliver M. Bautista, I. Chan, Joshua Chen, R. Gesser, Erin Moeller, Michael Ritter, S. Vuocolo, A. Luxembourg   +26 more
semanticscholar   +1 more source

Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study

Papillomavirus Research, 2017
Background: Most college males are not immunized against the human papillomavirus (HPV) and are at high risk of HPV infection. Most research of correlates of HPV vaccine acceptability in college males has assessed vaccine acceptability as a binary ...
Ovidiu Tatar, Samara Perez, Anila Naz, Gilla K. Shapiro, Zeev Rosberger   +4 more
doaj   +1 more source

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.

The Lancet Oncology, 2020
BACKGROUND Oncogenic human papillomavirus (HPV) infections cause most cases of cervical cancer. Here, we report long-term follow-up results for the Costa Rica Vaccine Trial (publicly funded and initiated before licensure of the HPV vaccines), with the ...
C. Porras, Sabrina H. Tsang, R. Herrero, Diego Guillén, T. Darragh, M. Stoler, A. Hildesheim, Sarah Wagner, J. Boland, D. Lowy, J. Schiller, M. Schiffman, John Schussler, M. Gail, W. Quint, Rebeca Ocampo, J. Morales, A. Rodriguez, Shangying Hu, J. Sampson, A. Kreimer   +20 more
semanticscholar   +1 more source

Understanding How Adolescents Think about the HPV Vaccine

Vaccines, 2020
Despite educational efforts, Tennessee human papillomavirus (HPV) vaccination rates are 43%, among the lowest in the United States. This study examined how adolescents think about the HPV vaccine to identify patterns and misconceptions to enhance ...
Robyn A. Pennella, Katherine A. Ayers, Heather M. Brandt   +2 more
doaj   +1 more source

Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.

PLoS ONE, 2022
IntroductionWHO recommends vaccination against HPV for girls before sexual debut. Uganda started HPV vaccination in 2008 as pilot programs in 2 districts, followed by national roll out in 2015.
Lydia Patrick, Sabrina Bakeera-Kitaka, Joseph Rujumba, Oliver Ombeva Malande   +3 more
doaj   +1 more source

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Papillomavirus Research, 2016
Background: Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. Methods: We conducted a retrospective cohort study using the 2008–2011 MarketScan data to examine HPV vaccine ...
Guodong Liu, Lan Kong, Ping Du
doaj   +1 more source

Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia

Human Vaccines & Immunotherapeutics, 2021
Human papillomavirus (HPV), the most common sexually transmitted infection worldwide, is responsible for a variety of cancers. HPV vaccines can help prevent this infection and its potentially devastating carcinogenic outcomes.
Nada J. Farsi, Asala H. Baharoon, Afnan E. Jiffri, Hani Z. Marzouki, Mazin A. Merdad, Leena A. Merdad   +5 more
doaj   +1 more source

Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States

Frontiers in Public Health, 2023
IntroductionCompared to other-race peers, Black women are disproportionately impacted by human papillomavirus [HPV] infection, related health outcomes, and cervical cancer mortality as a result of suboptimal HPV vaccine uptake during adolescence.
Aaliyah Gray, Aaliyah Gray, Celia B. Fisher, Celia B. Fisher   +3 more
doaj   +1 more source

Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics

Journal of Medical Internet Research, 2020
Background The human papillomavirus (HPV) vaccine is a major advancement in cancer prevention and this primary prevention tool has the potential to reduce and eliminate HPV-associated cancers; however, the safety and efficacy of vaccines in general and ...
Philip M. Massey, M. Kearney, Michael K Hauer, P. Selvan, E. Koku, A. Leader   +5 more
semanticscholar   +1 more source

HPV Vaccine Recommendations and Parental Intent

Pediatrics, 2021
Adolescents’ receipt of the human papillomavirus (HPV) vaccine is primarily a decision of their parents. Health care providers’ recommendation increases parents’ likelihood of initiating the HPV vaccine for their child.
K. Sonawane, Yenan Zhu, Yueh-Yun Lin, Haluk Damgacioglu, Ying Lin, J. Montealegre, A. Deshmukh   +6 more
semanticscholar   +1 more source